3.5. Erk1/2 Inhibitor Ravoxertinib Decreases ROS Production and Enhances Expression of ROS Scavengers in HNSCC Cells in Response to Erastin. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.